P. Regnault

471 total citations
7 papers, 327 citations indexed

About

P. Regnault is a scholar working on Immunology, Dermatology and Pathology and Forensic Medicine. According to data from OpenAlex, P. Regnault has authored 7 papers receiving a total of 327 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Immunology, 5 papers in Dermatology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in P. Regnault's work include Psoriasis: Treatment and Pathogenesis (6 papers), Dermatology and Skin Diseases (5 papers) and Autoimmune Bullous Skin Diseases (3 papers). P. Regnault is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (6 papers), Dermatology and Skin Diseases (5 papers) and Autoimmune Bullous Skin Diseases (3 papers). P. Regnault collaborates with scholars based in United States, Switzerland and Germany. P. Regnault's co-authors include Ulrich Mrowietz, Jacek C. Szepietowski, Giampiero Girolomoni, Darryl Toth, Craig L. Leonardi, C. Papavassilis, Akimichi Morita, John Sullivan, R. You and Kristian Reich and has published in prestigious journals such as Annals of the Rheumatic Diseases, Journal of the American Academy of Dermatology and British Journal of Dermatology.

In The Last Decade

P. Regnault

5 papers receiving 326 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
P. Regnault United States	5	307	204	86	54	48	7	327
S. Jazayeri United States	7	412 1.3×	278 1.4×	98 1.1×	73 1.4×	53 1.1×	10	443
Natalia Rompoti Greece	10	232 0.8×	194 1.0×	97 1.1×	47 0.9×	93 1.9×	26	326
Hany Elmaraghy United States	9	261 0.9×	315 1.5×	62 0.7×	66 1.2×	17 0.4×	30	419
Kamyar Farahi United States	7	209 0.7×	150 0.7×	28 0.3×	50 0.9×	38 0.8×	7	300
Toshihiro Ito Japan	9	233 0.8×	130 0.6×	27 0.3×	52 1.0×	35 0.7×	15	294
Arvin Ighani Canada	12	228 0.7×	150 0.7×	59 0.7×	34 0.6×	18 0.4×	19	290
A. Galluccio Italy	9	188 0.6×	153 0.8×	29 0.3×	64 1.2×	11 0.2×	11	265
MA Radtke Germany	6	287 0.9×	135 0.7×	25 0.3×	162 3.0×	35 0.7×	10	346
M. Viguier France	7	185 0.6×	144 0.7×	37 0.4×	37 0.7×	13 0.3×	12	247
Susumu Kitamura Japan	6	146 0.5×	132 0.6×	26 0.3×	63 1.2×	17 0.4×	6	220

Countries citing papers authored by P. Regnault

Since Specialization

Citations

This map shows the geographic impact of P. Regnault's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Regnault with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Regnault more than expected).

Fields of papers citing papers by P. Regnault

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Regnault. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Regnault. The network helps show where P. Regnault may publish in the future.

Co-authorship network of co-authors of P. Regnault

This figure shows the co-authorship network connecting the top 25 collaborators of P. Regnault. A scholar is included among the top collaborators of P. Regnault based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Regnault. P. Regnault is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Gottlieb, A.B., А. А. Кубанов, Martijn B. A. van Doorn, et al.. (2020). A study of the drug secukinumab in the treatment of palmoplantar psoriasis. British Journal of Dermatology. 182(4).

2.

Reich, Kristian, John Sullivan, Petr Arenberger, et al.. (2020). Secukinumab shows high and sustained efficacy in nail psoriasis: 2.5‐year results from the randomized placebo‐controlled TRANSFIGURE study*. British Journal of Dermatology. 184(3). 425–436. 41 indexed citations

3.

Gottlieb, Alice B., А. А. Кубанов, Martijn B. A. van Doorn, et al.. (2019). Sustained efficacy of secukinumab in patients with moderate‐to‐severe palmoplantar psoriasis: 2·5‐year results from GESTURE , a randomized, double‐blind, placebo‐controlled trial. British Journal of Dermatology. 182(4). 889–899. 27 indexed citations

4.

Reich, Kristian, John Sullivan, Petr Arenberger, et al.. (2018). Effect of secukinumab on the clinical activity and disease burden of nail psoriasis: 32‐week results from the randomized placebo‐controlled TRANSFIGURE trial. British Journal of Dermatology. 181(5). 954–966. 76 indexed citations

5.

Reich, Kristian, John Sullivan, Petr Arenberger, et al.. (2016). FRI0460 Secukinumab Shows Significant Efficacy in Nail Psoriasis: Week 32 Results from The Transfigure Study. Annals of the Rheumatic Diseases. 75. 603–604. 12 indexed citations

6.

Mrowietz, Ulrich, Craig L. Leonardi, Giampiero Girolomoni, et al.. (2015). Secukinumab retreatment-as-needed versus fixed-interval maintenance regimen for moderate to severe plaque psoriasis: A randomized, double-blind, noninferiority trial (SCULPTURE). Journal of the American Academy of Dermatology. 73(1). 27–36.e1. 170 indexed citations

7.

Regnault, P., et al.. (1967). [Barraquer-Simons cephalothoracic lipodystrophy].. PubMed. 96(3). 286–9. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact